Purdue Pharma nabs court approval for $397M sale of consumer health unit
A federal bankruptcy judge on Tuesday approved Purdue Pharma’s $397 million sale of its consumer health unit to a subsidiary of Arcadia Consumer Healthcare. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.